96-Sample Parallel BioSPME-DART-MS Platform for Rapid Screening of Fentanyl and its Analogues in Biofluids
Analytical Chemistry · 10.11.2026 · 98 (44) · 31703-31711
DOI: 10.1021/acs.analchem.6c05559 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 08.10.2026. Verfasst von Wei Zhou und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai519082, China. Hauptthemen laut MEDLINE: Fentanyl, Solid Phase Microextraction. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Solid-phase microextraction (SPME) with biocompatible coating material is highly compatible with ambient mass spectrometry (AMS), such as direct analysis in real time (DART), for improving sensitivity and reducing matrix effects. However, the practical throughput of SPME−DART-MS remains limited by the mismatch between parallel sample preparation and device-to-source transfer. Here, we introduce a 96-sample parallel BioSPME-DART-MS platform that integrates automated SPME extraction, 96-channel liquid transfer, and a matched 96-position DART mesh interface. This design enables 96 biological samples to be processed in a plate-based format, greatly improves workflow transferability. Thin HLB/PAN-coated SPME blades were used to provide bio-compatible extraction and cleanup from whole blood, plasma, and urine. After desorption in 200 μL of solvent, only 5 μL of the extract was transferred to the DART mesh for rapid MS/MS screening, while the remaining solution was retained for sequential LC−MS/MS confirmation without additional sample preparation. The system enabling an average analysis time of approximately 40 s per sample. Using six fentanyl and its analogues as model analytes, the BioSPME-DART-MS method achieved good sensitivity across the three biofluids, with limits of detection of 0.10−0.50 ng mL−1 in whole blood, 0.03−0.20 ng mL−1 in plasma, and 0.01−0.20 ng mL−1 in urine. In addition, a comparative study of absolute matrix effects revealed that chromatography-free DART-MS and blade spray-MS remained susceptible to ion suppression, whereas LC−ESI-MS showed negligible matrix effects. This platform establishes a high-throughput, two-tier SPME−MS workflow that combines rapid ambient MS screening with chromatography-based confirmation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai519082, China.
- Department of Chemistry, University of Waterloo, Waterloo, ONN2L 3G1, Canada.
ORCID-Profile: Wei Zhou, Janusz Pawliszyn
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Zhou, W., Driezen, M., & Pawliszyn, J. (2026). 96-Sample Parallel BioSPME-DART-MS Platform for Rapid Screening of Fentanyl and its Analogues in Biofluids. Analytical Chemistry, 98(44), 31703-31711. https://doi.org/10.1021/acs.analchem.6c05559
Vancouver
Zhou W, Driezen M, Pawliszyn J. 96-Sample Parallel BioSPME-DART-MS Platform for Rapid Screening of Fentanyl and its Analogues in Biofluids. Analytical Chemistry. 2026;98(44):31703-31711. doi:10.1021/acs.analchem.6c05559
BibTeX
@article{Zhou2026,
author = {Zhou, Wei and Driezen, Marc and Pawliszyn, Janusz},
title = {96-Sample Parallel BioSPME-DART-MS Platform for Rapid Screening of Fentanyl and its Analogues in Biofluids},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {44},
pages = {31703--31711},
doi = {10.1021/acs.analchem.6c05559}
}
EUVIMED